Postday One-step Tablet
Product Images NDC 69953-617

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Postday One-step (NDC 69953-617). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rapha Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Postday (Fda Spl Filing 628)

The image shows the packaging label for PostDay One-Step Levonorgestrel Tablet, 1.5 mg, an oral tablet manufactured for Rapha Pharmaceuticals, Inc. The label includes the product name, active ingredient, strength, dosage form, NDC code 69953-628-60, and states that the package contains 1 tablet. The front panel highlights usage instructions and the product's purpose as an emergency contraceptive.*

FDA Label Image

Postday (Fda Spl Filing 617)

PostDay One-Step Levonorgestrel Tablet 1.5 mg packaging label. This oral emergency contraceptive tablet by Rapha Pharmaceuticals features clear branding with dosage strength, usage instructions, and warnings. The label highlights that it contains one tablet intended to reduce the chance of pregnancy after unprotected sex, with a pink-themed graphic design and detailed drug facts on the side panel.*

FDA Label Image

Fda Spl Filing 618 (Fda Submission Artwork 618)

Packaging label for PostDay One-Step Levonorgestrel Tablet 1.5 mg by Rapha Pharmaceuticals, Inc. The label states it is an emergency contraceptive that reduces chance of pregnancy after unprotected sex. The box contains one oral tablet. Additional details include Drug Facts, usage instructions, warnings, and contact information for questions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.